vilpin combi 5 mg + 5 mg tabletki
teva b.v. - perindoprili tosilas + amlodipini besilas - tabletki - 5 mg + 5 mg
vilpin combi 10 mg + 10 mg tabletki
teva b.v. - perindoprili tosilas + amlodipini besilas - tabletki - 10 mg + 10 mg
vilpin combi 10 mg + 5 mg tabletki
teva b.v. - perindoprili tosilas + amlodipini besilas - tabletki - 10 mg + 5 mg
vilpin combi 5 mg + 10 mg tabletki
teva b.v. - perindoprili tosilas + amlodipini besilas - tabletki - 5 mg + 10 mg
calsus 25 000 iu kapsułki miękkie
teva b.v. - cholecalciferolum - kapsułki miękkie - 25 000 iu
sugammadex teva 100 mg/ml roztwór do wstrzykiwań
teva b.v. - sugammadexum natricum - roztwór do wstrzykiwań - 100 mg/ml
solifenacin stada 5 mg tabletki powlekane
stada arzneimittel ag - solifenacini succinas - tabletki powlekane - 5 mg
solifenacin stada 10 mg tabletki powlekane
stada arzneimittel ag - solifenacini succinas - tabletki powlekane - 10 mg
levetiracetam teva 1500 mg tabletki powlekane
teva b.v. - levetiracetamum - tabletki powlekane - 1500 mg
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - białaczka, szpikowe - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.